Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CaSR Expression in Septic Shock
NCT06853340Recruiting
- Sponsor
- CHU Amiens-Picardie
- Start
- Feb 2025
- Primary completion
- Apr 2025
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by CHU Amiens-Picardie. Primary endpoint: Monocyte Calcium Sensing Receptor expression at Day 7. Started Feb 2025; status: recruiting.
Beyond the preview
Go deeper on NCT06853340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06853340.